Dr. Nils Morgenthaler studied medicine at the University of Ulm and wrote his academic thesis in endocrinology. He completed his training at the university hospitals of Ulm and Leipzig, and at King’s College Hospital in London, specializing in internal medicine.
He left clinical medicine in 1997 to work for BRAHMS GmbH and played a key role in bringing novel in vitro diagnostic assays from bench to bedside, including TSH-receptor autoantibodies, Procalcitonin and Copeptin. After getting an executive MBA from the University of Potsdam, he became General Manager for GILUPI GmbH, and subsequently, Vice President for Clinical Business Development at BRUKER Daltonics in Bremen. He joined InVivo Biotech Services as General Manager in 2017.
Dr. Morgenthaler has more than 20 years of management experience in the diagnostic industry, and a long track record of research collaborations, with over 200 scientific publications covering the fields of endocrinology/diabetes, infectious diseases/sepsis, cardiology and oncology.

Caterina holds a Master´s degree in Chemistry with a specialization in Biochemistry and Protein production. Caterina has proudly represented InVivo’s Marketing and Business Development department for more than 10 years. She managed acquisitions, contributed to market outreach and optimized internal functions. 2019 onwards, she absorbs process control responsibilities in Antibody and Protein production while continuing as the chief consult for expanding InVivo’s business internationally.

Moath holds a PhD in Immunology from the University Hospital Carl Gustav Carus in Dresden, Germany and a Global Executive Master of Business Administration from HHL University in Leipzig, Germany and EADA University in Barcelona, Spain. He has 12 years of experience in immunology research and more than 8 years of experience in business development in various global life science companies.

Moath joined InVivo in 2022 and is responsible for Customer Service, Sales & BD and Marketing. Moreover, he is responsible for distributor management and licensing as well as the cooperation strategy with internal and external business partners.

Caren received her master’s degree in biology from the University of Duesseldorf. Afterwards, she spent 3 years at the Fraunhofer Institute for Applied Polymer Research, working in-depth on protein modification and large-scale recombinant protein production.

In 2022, Caren joined InVivo as a Key Account Manager and has since been responsible for key customers from North and Sount America, Great Britain and the Nordic Region.

Sandra acquired a Diploma in Biotech Engineering as well as her Masters of Science in Drug Development from the University of Karlsruhe, Germany and Strasbourg (France). She spent close to 9 months in Ipswich, USA as a part of her Diploma Thesis and holds additional experience of close to 6 years in laboratory research. She joined InVivo in 2019 to support a growing base of customers in the DACH and North American Region. In addition to being a key member of the Customer Service team, she is in-charge of InVivo’s social media engagement and represents the team in networking events.

Janina holds a Master of Science degree from the Humboldt University of Berlin with a specialization in the field of virology. Her career has focused on international standards that specify requirements for a quality management system and FDA regulations for in vitro diagnostics and medical devices. Janina has quality management experience in the biotechnology industry for more than 10 years. She joined InVivo BioTech Services GmbH in 2016 as the head of the quality management department. She ensures the compliance with regulations of products and services that meet the needs of the customer and the requirements of the organization.